Gene ontology Gene full name/Function Gene symbol (fold-change and p-value)
ECM proteolytic activity, Collagen formation & focal adhesion collagen, procollagen C-endopeptidase enhancer, Lysis oxidase, collagen triple helix repeat containing 1, fibrillin, fibronectin, versican, hyaluronic acid (HA) receptor, Metalloproteinase, EGF containing fibulin-like extracellular matrix protein 2, elastin, spondin 1, extracellular matrix protein, lumican, fibroblast growth factor 9, Tissue growth factor, periostinosteoblast specific factor Col1a1 (5.36, 0.0001), Col5a1 (3.65, 0.0006), Col5a2 (4.84, 0.0004), Col4a1 (3.61, 0.01), Col6a3 (3.64, 0.01), Col1a2 (4.20, 0.0003), Col3a1 (4.08, 0.0006), Pcolce (4.05, 0.003), Loxl1 (3.27, 0.0037), Cthrc1 (6.17, 0.0005), Fbn1 (4.45, 0.0002), Fn1 (4.83, 0.0005), Vcan (3.63, 0.0001), CD44 (1.83, 0.0031), MMP14 (3.82, 0.0012), MMP19 (2.19, 0.0011), MMP23 (2.38, 0.0022), Timp1 (7.40, 0.0049), Efemp2 (3.36, 0.0031), Eln (3,21, 0.0016), Spon1 (3.37, 0.0007), Lum (2.57, 0.0179), FGF9 (-1.61, 0.0414), CTGF (3.07, 0.0015), TGFb1 (1.50, 0.0315), Postn (14.94, 0.00001)
Complement Cascades & Immune response Complement factor, Integrin alpha, leukocyte immunoglobulin-like receptor, Fc fragment of IgG, colony stimulating factor 2 receptor, beta C3ar1 (2.75, 0.0028), C3 (4.13, 0.0164), C6 (2.99, 0.0112), C1r (2.08, 0.0193), C2 ( 2.72, 0.0410), Itgam (3.82, 0.001), Lilrb4 (3.20, 0.0009), Fcgr1a (3.23, 0.0029), Csf2rb (3.33, 0.0124)
Blood vessel formation & angiogenesis tubulin, beta 6, Heme oxigenase, Cys-rich angiogenic inducer 61, alanyl aminopeptidase Tubb6 (3.29, 0.0076), Hmox1 (6.99, 0.0001), Cyr61 (3.30, 0.0283), Anpep (4.05, 0.0003)
Muscle contraction & Ca2+ signal tropomyosin 1, regulates ca-dep interaction of actin- myosin, Myoferlin, Myoferlin Tpm2 (3.60, 0.0035), MyoF (2.26, 0.0059), Myo1f (2.80, 0.0070)
Lipid Phospholipase A2 Pla2g2a (2.53, 0.0084), Pla2g15 (1.77, 0.0075)
Cell cycle arrest & apoptosis FBJ osteosarcoma viral oncogene homolog, pleiomorphic adenoma gene-like 1, lipocalin 2, lysozyme fos (1.77, 0.0178), Plagl1 (3.49, 0.038), Lcn2 (4.14, 0.0029), Lyz2 (2.74, 0.0338)
Protein trafficking & phagosomal RAS oncogene family, lysosomal/endosomal-associated membrane glycoprotein Rab13 (1.90, 0.011), Rab32 (2.07, 0.0011), CD68 (3.69, 0.0003)
Metabolism glutathione peroxidase 7, pyruvate dehydrogenase kinase, isozyme 2, hemochromatosis type 2, heat shock 70kDa protein 4-like, protein folding Gpx7 (3.34, 0.0174), Pdk2 (-1.97, 0.0267), Hfe2 (-2.14, 0.026), Hspa4l (-1.67, 0.0365)
Mitochondrial activity cytochrome b-245, NADH dehydrogenase (ubiquinone), GrpE-like 1, mitochondrial Cybb (3.12, 0.0023), Ndufs4 (-2.26, 0.0157), Grpel1 (-1.69, 0.0274)
Fatty acid & cholesterol catabolism peroxisomal membrane protein 2, apolipoprotein E Pxmp2 (-1.77, 0.0347), ApoE (1.66, 0.0054)
Glucose transport HtrA serine peptidase,may regulate insulin-likeGFs availability, insulin Htra1 (3.36, 0.0244), Ins1 (-1.67, 0.0441)
Table 1: A list of genes whose expression is modified compared to sham upon MI only [FC> (+1.5) or FC< (-1.5), p<0.05] according to the gene chip array. Genes are affiliated with a specific KEGG pathway related to the cardiac structure or function. Only genes demonstrating best differential expression in the MI group relative to sham, are listed.